BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2947648)

  • 1. Thermospray liquid chromatography/mass spectrometry of ether phosphocholines.
    Mallet AI; Rollins K
    Biomed Environ Mass Spectrom; 1986 Oct; 13(10):541-3. PubMed ID: 2947648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural identification of platelet activating factor in psoriatic scale.
    Mallet AI; Cunningham FM
    Biochem Biophys Res Commun; 1985 Jan; 126(1):192-8. PubMed ID: 3970690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desorption chemical ionization mass spectrometry of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines and analogues.
    Thomas MJ; Samuel M; Wykle RL; Surles JR; Piantadosi C
    J Lipid Res; 1986 Feb; 27(2):172-6. PubMed ID: 3958619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and quantitation of PAF from psoriatic scales.
    Ramesha CS; Soter N; Pickett WC
    Agents Actions; 1987 Aug; 21(3-4):382-3. PubMed ID: 3687590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric evidence for the presence of platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid during labor.
    Nishihira J; Ishibashi T; Imai Y; Muramatsu T
    Lipids; 1984 Dec; 19(12):907-10. PubMed ID: 6527609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of platelet-activating factor by high-performance liquid chromatography with fluorescent detection.
    Mita H; Yasueda H; Hayakawa T; Shida T
    Anal Biochem; 1989 Jul; 180(1):131-5. PubMed ID: 2817335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of selected ion monitoring to determination of platelet-activating factor.
    Satouchi K; Oda M; Yasunaga K; Saito K
    J Biochem; 1983 Dec; 94(6):2067-70. PubMed ID: 6423622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of platelet-activating factor in biological samples using liquid chromatography/mass spectrometry with column-switching technique.
    Oda Y; Mano N; Asakawa N
    Anal Biochem; 1995 Oct; 231(1):141-50. PubMed ID: 8678293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor (PAF) and lyso-PAF in psoriasis.
    Judge MR; Barr RM; Mallet AI; Courtney F; Kobza Black A; Greaves MW
    Arch Dermatol Res; 1994; 286(7):376-9. PubMed ID: 7818279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel molecular analogues of phosphatidylcholines in a lipid extract from bovine brain: 1-long-chain acyl-2-short-chain acyl-sn-glycero-3-phosphocholines.
    Tokumura A; Takauchi K; Asai T; Kamiyasu K; Ogawa T; Tsukatani H
    J Lipid Res; 1989 Feb; 30(2):219-24. PubMed ID: 2715726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
    Shindo K; Hashimoto Y
    Drugs Exp Clin Res; 1991; 17(7):343-9. PubMed ID: 1794300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry.
    Kita Y; Takahashi T; Uozumi N; Shimizu T
    Anal Biochem; 2005 Jul; 342(1):134-43. PubMed ID: 15958190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and quantification of PAF-acether (platelet-activating factor) as a heptafluorobutyrate derivative of 1-O-alkyl-2-acetyl-sn-glycerol by capillary column gas chromatography with electron-capture detection.
    Bossant MJ; Farinotti R; Mencia-Huerta JM; Benveniste J; Mahuzier G
    J Chromatogr; 1987 Dec; 423():23-31. PubMed ID: 3443654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid isocratic high-performance liquid chromatographic purification of platelet activating factor (PAF) and lyso-PAF from human skin.
    Mallet AI; Cunningham FM; Daniel R
    J Chromatogr; 1984 Jul; 309(1):160-4. PubMed ID: 6480761
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry.
    Haroldsen PE; Gaskell SJ
    Biomed Environ Mass Spectrom; 1989 Jun; 18(6):439-44. PubMed ID: 2504312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an automated thermospray liquid chromatography-mass spectrometry system for quantitative use in bioanalytical chemistry.
    Lindberg C; Paulson J; Blomqvist A
    J Chromatogr; 1991 Aug; 554(1-2):215-26. PubMed ID: 1795037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric analysis of endogenous diacylglycerols in normal and psoriatic skin.
    Mallet AI; McLaughlin-Flynn CA; Camp RD
    J Chromatogr; 1988 Nov; 432():278-82. PubMed ID: 3220895
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of the platelet activating factor antagonist 6-(2- chlorophenyl)-9-[(4-methoxyphenyl)thiocarbamoyl]-1-methyl-7,8,9,10- tetrahydro-4H-pyrido[4',3'-4,5]-thieno[3,2-f][1,2,4]triazolo[4, 3-a][1,4] diazepine in human plasma by liquid chromatography-thermospray mass spectrometry.
    Celma C
    J Chromatogr B Biomed Appl; 1994 Jul; 657(1):214-8. PubMed ID: 7952071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry.
    Ramesha CS; Pickett WC
    Biomed Environ Mass Spectrom; 1986 Mar; 13(3):107-11. PubMed ID: 2938649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
    Balazy M; Braquet P; Bazan NG
    Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.